Herpes Simplex Virus Type 1 DNA Amplified as Bacterial Artificial Chromosome inEscherichia coli:Rescue of Replication-Competent Virus Progeny and Packaging of Amplicon Vectors
- 10 December 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 9 (18) , 2787-2794
- https://doi.org/10.1089/hum.1998.9.18-2787
Abstract
Herpes simplex virus type 1 (HSV-l)-based amplicon vectors contain only ~ 1% of the 152-kb HSV-1 genome, and consequently, replication and packaging into virions depends on helper functions. These helper functions have been provided conventionally by a helper virus, usually a replication-defective mutant of HSV-1, or more recently, by a set of five cosmids that overlap and represent the genome of HSV-1 deleted for DNA cleavage/packaging signals (pac). In the absence of pac signals, potential HSV-1 genomes that are reconstituted from the cosmids via homologous recombination are not packageable. The resulting amplicon stocks are, therefore, virtually free of contaminating helper virus. To simplify this packing system, the HSV-1 genome was cloned and maintained stably as a single-copy, F plasmid-based bacterial artificial chromosome in E. coli. Such a plasmid containing the HSV-1 genome deleted for the pac signals (fHSVΔ pac) did not generate replication-competent progeny virus on transfection into mammalian cells, but rather, it was able to support the packaging of cotransfected amplicon DNA that contained a functional pac signal. The resulting amplicon vector stocks had titers of up to 107 transducing units per milliliter of culture medium and efficiently transduced neural cells in the rat brain, as well as hepatocytes in the rat. The capacity of generating infectious and replication-competent HSV-1 progeny following transfection into mammalian cells was restored after insertion of a pac signal into fHSVΔpac.Keywords
This publication has 19 references indexed in Scilit:
- Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosomeProceedings of the National Academy of Sciences, 1997
- Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivoNeuroReport, 1997
- Gene Transfer into Hepatocytes Mediated by Helper Virus-Free HSV/AAV Hybrid VectorsMolecular Medicine, 1997
- HSV/AAV Hybrid Amplicon Vectors Extend Transgene Expression in Human Glioma CellsHuman Gene Therapy, 1997
- A Cosmid-Based System for Constructing Mutants of Herpes Simplex Virus Type 1Virology, 1993
- Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector.Proceedings of the National Academy of Sciences, 1992
- Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expressionVirology, 1992
- An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.Proceedings of the National Academy of Sciences, 1990
- The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1Journal of General Virology, 1988
- The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vectorCell, 1982